Media

Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development

Press Release: Prellis Biologics Announces Collaboration with Sanofi

Press Release: Prellis Biologics Announces Collaboration and License Agreement with Bristol Myers Squibb